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Abstract
Background: Emerging evidence suggested phytosterol esters (PE) exhibited an advantage over naturally occurring
phytosterols in reducing atherosclerosis risk factors due to improved fat solubility and compatibility. However, the
effects of dietary patterns of PE on lipid-lowering activity were limited and inconsistent. This study aimed to explore
the effects of dose and frequency of α-linolenic acid rich phytosterol esters (ALA-PE) on cholesterol and triglyceride
metabolism markers focused on intestinal cholesterol absorption and bioconversion of ALA in liver.
Methods: Dose-dependency study Male Syrian golden hamsters were fed high-fat diets (HFD) containing low,
medium and high dose of ALA-PE (0.72 %, 2.13 % and 6.39 %) for 6 weeks. The high fat diet contained 89.5 %
chow diet, 0.2 % cholesterol, 10 % lard and 0.3 % bile salt.
Dose-frequency study Male Syrian golden hamsters were provided: (I) 0.4 mL/100 g peanut oil by gavage once a
day; (II) 0.4 mL/100 g ALA-PE by gavage once a day; (III) 0.2 mL/100 g ALA-PE by gavage twice a day; (IV) 0.133 mL/100 g
ALA-PE by gavage three times a day; (V) 0.1 mL/100 g ALA-PE by gavage four times a day for 6 weeks with a high-fat
diet simultaneously.
Results: ALA-PE dose-dependently lowered plasma total cholesterol (TC), triglyceride (TG) and low-density lipoprotein
cholesterol (LDL-C) concentrations with a maximal decrease of 42 %, 59 % and 73 %, respectively (p < 0.05). Compared
to HFD, TC, LDL-C and TG concentrations were significantly lower (p < 0.01) in hamsters consumed HFD plus ALA-PE for
1–4 times per day but there were not remarkable differences among different consumption frequencies. No significant
changes in plasma antioxidant capacity and lipid peroxidation levels were observed among HFD and HFD plus different
doses of ALA-PE groups. The contents of hepatic α-linolenic (ALA), docosapentaenoic (DPA) and docosahexaenoic (DHA)
acids were dose-dependently increased in different ALA-PE groups compared to those in HFD group. The abundance of
mRNA for intestinal sterol transporters Niemann-Pick C1-Like 1 (NPC1L1), ATP-binding cassette (ABC) transporters ABCG5
and ABCG8 indicated no significant differences among all groups.
Conclusion: ALA-PE dose-dependently improved lipid profile in hamsters fed HFD independent of intestinal ABCG5,
ABCG8 and NPC1L1, accompanying by increased conversion of ALA to DPA and DHA in liver. ALA-PE manifested
“once a day” lipid-lowering efficacy, highlighting a promising preventive strategy for metabolic syndrome.
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Background
Although the declining trend in cardiovascular diseases
(CVDs) mortality has been observed in high-income
countries, CVDs are still the leading causes of noncom-
municable disease (NCD) deaths. Approximately 31 % of
global deaths were attributable to CVDs and most CVD
deaths occur in developing countries as reported in
2012 according to data from the WHO. Elevated
levels of total cholesterol (TC), especially low-density
lipoprotein cholesterol (LDL-C), and triglyceride (TG)
are major causes of atherosclerosis and subsequent
CVDs [1, 2]. Therefore, it is imperative to explore the
specific early intervention strategies for CVD preven-
tion and control.
Increasing evidence demonstrated that dietary modifi-
cations including diets rich in phytochemicals reduced
one or more risk factors of CVDs [3]. Phytosterols, as a
naturally occurring phytonutrient, are well-known as an
adjunct to pharmacologic therapy for the ability of inhi-
biting intestinal cholesterol absorption, thereby reducing
plasma cholesterol levels [4]. However, it was not yet
clear whether the sterols are taken up by enterocytes
through energy-independent passive diffusion or intes-
tinal sterol transporters mediated process [5]. Further-
more, the mechanism of action of phytosterols was still
enigmatic and being investigated. Currently, there were
three proposed effects based on cholesterol absorption
stages, including competitive solubilization and co-
crystallization at gastric duodenal levels, decreased hy-
drolysis of cholesterol esters in luminal micelle and
inhibited cholesterol transport from intestinal lumen to
lymph [6]. High doses of phytosterols intake were
needed to achieve maximal reductions of cholesterol
levels due to the weak solubility in both water and fat.
Esterification of phytosterols with fatty acids has been
suggested for improved compatibility and potential of
producing delivery systems for both phytosterols and es-
terified fatty acids [7, 8]. N-3 polyunsaturated fatty acids
(n-3 PUFAs) consumption was intimately associated
with reduced cardiovascular risk [9]. N-3 PUFAs rich phy-
tosterol esters were proved to evidently alleviate hyper-
cholesterolemia [10]. Within the n-3 series, α-linolenic
acid (ALA), as the precursors of eicosapentaenoic (EPA),
docosapentaenoic (DPA) and docosahexaenoic (DHA)
acids, may share some of the physiological and functional
attributes of n-3 long-chain PUFAs [11]. A recent study
revealed that ALA rich phytosterol esters showed im-
proved effect on lipid profile compared to EPA-DHA rich
phytosterol esters [12]. Therefore, the potential thera-
peutic advantage of phytosterols esterified with ALA
should be considered in order to maximize the lipid-
lowering activity.
Previous studies highlighted the influence of structure
variations at lateral chain and rings (oxyphytosterols) on
the absorption efficiency of phytosterols and subsequent
intestinal cholesterol metabolism [13]. More import-
antly, the cholesterol-lowering efficacy of phytosterols
was significantly affected by dietary background and in-
take modalities [14–17]. Nevertheless, it remained elu-
sive whether the esterified ALA in the lateral chain
affected the absorption and subsequent dose and fre-
quency response of phytosterols on lipid-lowering prop-
erties in a complementary or synergistic way. On the
basis of the biocatalyst prepared ALA rich phytosterol
esters, we investigated the effects of consumption dose
and frequency of ALA rich phytosterol esters on lipid-
lowering activity. Furthermore, the gene expression in-
volved in regulating intestinal sterol absorption, and the
conversion of ALA to n-3 long-chain PUFAs were con-
ducted to identify the underlying mechanisms that pro-
duce them.
Results
Body weight and food intake
As shown in Table 1, low, medium and high dose of
ALA-PE exhibited no significant inhibitory effect on
body weight gain after 6 weeks of high-fat feeding. The
weekly food intake among all groups also revealed no
significant differences throughout the whole experi-
mental period.
Plasma and hepatic lipid profiles
Dose dependency of α-linolenic acid rich phytosterol esters
supplementation
As shown in Fig. 1, low dose of ALA-PE partially re-
duced plasma TC, LDL-C and TG levels in hamsters fed
HFD, while middle and high doses of ALA-PE signifi-
cantly ameliorated HFD-induced increase of plasma TC,
LDL-C and TG levels (p < 0.05). Additionally, different
doses of ALA-PE continuously lowered plasma HDL-C
levels in hamsters fed HFD. Moreover, ALA-PE supple-
mentation decreased hepatic TC and TG concentrations
in HFD-fed hamsters in a dose-dependent manner, re-
vealing significant differences between HFD and middle,
high doses of ALA-PE treated groups (p < 0.05).
Table 1 Effect of α-linolenic acid rich phytosterol esters on
body weight and food intake of high fat fed hamsters
Groups Initial weight(g) Final weight(g) Food intake(g/day)
HFD 98.6 ± 3.3 117.3 ± 3.1 7.14 ± 1.26
L-ALA-PE 96.8 ± 4.7 121.5 ± 3.3 7.56 ± 2.55
M- ALA-PE 97.8 ± 2.8 117.6 ± 2.7 8.12 ± 2.34
H- ALA-PE 98.2 ± 3.8 118.7 ± 2.6 7.35 ± 2.31
HFD: High fat control group
L-ALA-PE: Low dose of α-linolenic acid rich phytosterol esters group
M-ALA-PE: Medium dose of α-linolenic acid rich phytosterol esters group
H-ALA-PE: High dose of α-linolenic acid rich phytosterol esters group
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Dose frequency of α-linolenic acid rich phytosterol esters
supplementation
The data in Fig. 2 showed that based on the same ad-
ministration dosage, intake frequency and time had no
effects on the lipid-lowering activity of ALA-PE. And
significant decrease in plasma TC (p < 0.01), TG (p < 0.05),
LDL-C levels (p < 0.01), as well as HDL-C (p < 0.01), were
observed in hamsters after different dose frequency of
ALA-PE supplementation.
Plasma antioxidant capacity and lipid peroxidation
Interestingly, no significant difference was observed in
SOD, GSH, GPX activities and T-AOC level between HFD
and HFD plus different doses of ALA-PE groups (Fig. 3).
Hepatic ALA, DPA and DHA levels
As manifested in Fig. 4, we found that ALA-PE significantly
increased the contents of hepatic ALA, DPA and DHA in
HFD-fed hamsters with a dose–response relationship. The
contents of ALA increased by 82 % (p < 0.05), 168 %
(p < 0.01) and 421 % (p < 0.01), concentrations of DPA in-
creased by 16 %, 33 % and 47 % (p < 0.05), and DHA levels
increased by 24 %, 31 % (p < 0.05) and 40 % (p < 0.05),
respectively, when compared with the HFD group.
Intestinal NPC1L1, ABCG5 and ABCG8 mRNA levels
As depicted in Fig. 5, different doses of ALA-PE exerted
no significant effects on the mRNA expressions of intes-
tinal sterol transporters NPC1L1, ABCG5 and ABCG8.
Discussion
The dose and frequency responses of α-linolenic acid rich
phytosterol esters supplementation
A dose–response relationship was exhibited between α-
linolenic acid rich phytosterol esters dose and plasma
lipid levels in our study. The results revealed that 0.72–
6.39 % phytosterol esters in HFD, approximately equiva-
lent to 2.4–8.9 g/d for people, continuously reduced
plasma TC, TG and LDL-C levels, as well as the hepatic
TC and TG concentrations. Similar dose-dependent
cholesterol-lowering effect of phytosterols-enriched mar-
garine was also observed in both statin users and non-
users [18]. Based on the mechanism of action of phytos-
terols, a continuous supply of phytosterol esters was
needed to interact with and facilitate the excretion of
gut cholesterol and bile acids. However, our data indi-
cated that comparable lipid-lowering effect was revealed
among the different consumption frequencies of phytos-
terol esters (1–4 times/day at daily consumption of
0.4 mL/100 g b.w), which agreed with findings from a
randomized, double-blind crossover study [19]. While the
other study reported that multiple smaller doses but not
one large dose of physterols showed greater cholesterol-
lowering effect [20]. Considering the differences in
cholesterol-lowering efficacy between phytosterol esters
and free phytosterols induced by frequency of intake, the
fatty acids delivered by phytosterol esters may increase the
gastrointestinal responses to phytosterols similar to meal
intake, allowing phytosterol esters to continuously exhibit
Fig. 1 Effect of dose–response of α-linolenic acid rich phytosterol esters on plasma lipid levels of high fat fed hamsters. a The plasma TC and TG.
b The plasma HDL-C, LDL-C and LDL/HDL. c The hepatic TC and TG. # p < 0.05 vs. HFD, ## p < 0.01 vs. HFD; HFD: High fat control group; L-ALA-PE:
Low dose of α-linolenic acid rich phytosterol esters group; M-ALA-PE: Medium dose of α-linolenic acid rich phytosterol esters group; H-ALA-PE:
High dose of α-linolenic acid rich phytosterol esters group
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Fig. 3 Effect of α-linolenic acid rich phytosterol esters on plasma antioxidant capacity and lipid peroxidation of high fat fed hamsters. a Plasma
SOD (b) Plasma GPX (c) Plasma T-AOC (d) Plasma GSH. # p < 0.05 vs. HFD, ## p < 0.01 vs. HFD; HFD: High fat control group; L-ALA-PE: Low dose of
α-linolenic acid rich phytosterol esters group; M-ALA-PE: Medium dose of α-linolenic acid rich phytosterol esters group; H-ALA-PE: High dose of
α-linolenic acid rich phytosterol esters group
Fig. 2 Effect of dose-frequency of α-linolenic acid rich phytosterol esters on plasma lipid levels of high fat fed hamsters. # p < 0.05 vs. HFD,
## p< 0.01 vs. HFD; HFD: High fat control group; ALA-PE1: α-linolenic acid rich phytosterol esters group1, received α-linolenic acid rich phytosterol esters
by gavage once a day; ALA-PE2: α-linolenic acid rich phytosterol esters group2, received α-linolenic acid rich phytosterol esters by gavage twice a day;
ALA-PE3: α-linolenic acid rich phytosterol esters group3, received α-linolenic acid rich phytosterol esters by gavage three times a day; ALA-PE4: α-linolenic
acid rich phytosterol esters group4, received α-linolenic acid rich phytosterol esters by gavage four times a day
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their effect on inhibiting cholesterol absorption independ-
ent of the intake occasion [15]. Furthermore, the length of
experimental period may affect the frequency-response of
phytosterol esters to manifest itself.
The molecular mechanisms of α-linolenic acid rich
phytosterol esters supplementation
Triglycerides are considered to be an independent risk
factor for CVD. Recent studies reported that combin-
ation of phytosterols and n-3 PUFA reduced CVD risk
in a complementary and synergistic way [21]. Our study
revealed that α-linolenic acid rich phytosterol esters con-
sumption was associated with dose-dependently reduced
plasma and hepatic triacylglycerol levels. The TG-lowering
effect of phytosterol esters mainly attributed to the esteri-
fied α-linolenic acid in side chain. Furthermore, the ex-
panded evidence of α-linolenic acid for TG-lowering effect
was intimately associated with its conversion to EPA, DPA
and DHA, which had a higher efficacy in modulating
physiological responses [11]. Our analyses demonstrated
that significantly increased DPA and DHA levels were
incorporated into the hepatic lipid pools of hamsters
fed α-linolenic acid rich phytosterol esters. Mechanically,
α-linolenic acid exerted most of its effects by modulating
lipoprotein (a) and apolipoproteins A-1 and B. EPA and
DHA exerted most of its TG-lowering effects by reducing
TG synthesis through regulating the hepatic expression of
sterol regulatory element-binding protein-1 (SREBP-1).
Furthermore, long chain n-3 PUFA up-regulated the ex-
pression of peroxisomal acyl-CoA oxidase, carnitine palmi-
toyl transferase 1 (CPT1) and mitochondrial uncoupling
proteins, which facilitated fatty acid β-oxidation in liver
mitochondria [9].
N-3 PUFA rich phytosterol esters are now well-known
dietary adjuncts that effectively lower cholesterol levels
[12]. As shown in this study, significant and dose-
dependent cholesterol-lowering effects of α-linolenic
acid rich phytosterol esters were revealed in hamster fed
HFD. The hydrolysis of phytosterol esters and the pres-
ence of free phytosterols were proved to be necessary to
induce an optimum cholesterol-lowering effect [22].
However, the exact mechanism of action of phytosterols
remained to be clearly understood. Although the dis-
placement of cholesterol from mixed micelles within
the intestinal lumen seemed to be an important mechan-
ism of action of phytosterols [6]. Recent researches re-
vealed that the sterol transporters Niemann-Pick C1-Like
1 (NPC1L1), ABCG5 and ABCG8 were critical in regulat-
ing cholesterol flux at the intestinal enterocyte level [23].
Therefore, it is reasonable to speculate that phytosterols
may decrease cholesterol absorption through regulating
the expression of intestinal NPC1L1, ABCG5 and ABCG8.
However, the results in current study do not support this
hypothesis. α-linolenic acid rich phytosterol esters exerted
no significant effect on the mRNA expressions of
NPC1L1, ABCG5 and ABCG8 in intestine, indicating
Fig. 4 Effect of α-linolenic acid rich phytosterol esters on hepatic fatty acid composition of high fat fed hamsters. # p < 0.05 vs. HFD, ## p < 0.01 vs.
HFD; HFD: High fat control group; L-ALA-PE: Low dose of α-linolenic acid rich phytosterol esters group; M-ALA-PE: Medium dose of α-linolenic
acid rich phytosterol esters group; H-ALA-PE: High dose of α-linolenic acid rich phytosterol esters group
Fig. 5 Effect of α-linolenic acid rich phytosterol esters on mRNA levels of
intestinal ABCG5, ABCG8 and NPC1L1 of high fat fed hamsters. # p< 0.05
vs. HFD, ## p< 0.01 vs. HFD; HFD: High fat control group; L-ALA-PE: Low
dose of α-linolenic acid rich phytosterol esters group; M-ALA-PE: Medium
dose of α-linolenic acid rich phytosterol esters group; H-ALA-PE: High
dose of α-linolenic acid rich phytosterol esters group
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that α-linolenic acid phytosterol esters decreased plasma
cholesterol independently of the gene expression of the
influx and efflux transporters. Our results were consistent
with preliminary studies conducted in hamsters supple-
mented with stanol esters [24, 25]. Of course, these findings
could not exclude the possible changes in protein expres-
sion or activity of these sterol transporters through post-
transcriptional regulation by phytosterol esters. In addition,
other alternative mechanisms might be involved in
decreased plasma cholesterol concentration by α-linolenic
acid rich phytosterol esters, including the regulation of
endogenous cholesterol synthesis through inhibition of 3-
hydroxy-3-methylglutaryl-CoA reductase (HMGR), or acti-
vation of the liver X receptor (LXR) target pathways [26].
In all, these compounds act on multiple targets, phytos-
terols have long been recognized for their cholesterol-
lowering action with little effects on triacylglycerol
[27, 28]. However, one recent research has highlighted the
complementary plasma triglyceride-lowering responses to
phytosterols, which was associated with decreased hepatic
VLDL secretion [29]. Moreover, in response to phytosterol
esters supplement, hamsters manifested a lower plasma
HDL-C levels in a dose-dependent manner than those
in high-fat diet fed animals, which indicated that the
cholesterol-lowering effect of phytosterol esters was partly
due to promoting the selective uptake of cholesteryl ester
from HDL mediated by increased protein expressions of
SR-BI, the first molecularly well-defined and physiologically
relevant HDL receptor [30, 31].
Conclusion
α-linolenic acid rich phytosterol esters dose-dependently
attenuated HFD induced abnormal lipid metabolism
independent of the expression of intestinal sterol trans-
porters NPC1L1, ABCG5 and ABCG8, paralleling with
increased DPA and DHA levels synthesized from α-
linolenic acid. Moreover, α-linolenic acid rich phytosterol
esters manifested“once a day efficacy” on reductions of
serum lipid levels during 6 weeks of consumption.
Methods
Chemicals and materials
α- linolenic acid rich phytosterols esters was prepared by
enzymatic catalysis in our laboratory.
Animal treatment
Male Syrian golden hamsters weighing 90–100 g were
obtained from Wuhan Institute of Biological Products
Co., Ltd. The animals were housed in stainless steel cages
at a controlled room temperature (22 ± 2 °C) and a relative
humidity (65 %–75 %) with a 12:12 light dark cycle. The
animals were taken care of according to the Guiding
Principles in the Care and Use of Laboratory Animals
published by the US National Institutes of Health.
Dose-dependency study
After one week of acclimatization with chow diet, the
animals were randomly divided into 5 groups of 10
animals in each with high fat diet for 6 weeks as the
following: (I) High fat control group (HFD), received
93.61 % high fat diet and 6.39 % corn starch; (II) Low
dose of α-linolenic acid rich phytosterol esters group
(L-ALA-PE), received 93.61 % high fat diet, 0.72 % α-
linolenic acid rich phytosterol esters and 5.67 % corn
starch; (III) Medium dose of α-linolenic acid rich phytos-
terol esters group (M-ALA-PE), received 93.61 % high fat
diet, 2.13 % α-linolenic acid rich phytosterol esters and
4.26 % corn starch; (IV) High dose of α-linolenic acid rich
phytosterols esters group (H-ALA-PE), received 93.61 %
high fat diet and 6.39 % α-linolenic acid rich phytosterol
esters. The high fat diet contained 89.5 % chow diet, 0.2 %
cholesterol, 10 % lard and 0.3 % bile salt.
Dose-frequency study
After one week of acclimatization with chow diet, the
animals were randomly divided into 5 groups of 10 ani-
mals in each with high fat diet for 6 weeks as the follow-
ing: (I) High fat control group (HFD), administered
0.4 mL/100 g of peanut oil by gavage once a day at
9 AM; (II) α-linolenic acid rich phytosterol esters group
1 (ALA-PE1), received 0.4 mL/100 g α-linolenic acid
rich phytosterol esters by gavage once a day at 9 AM;
(III) α-linolenic acid rich phytosterol esters group 2
(ALA-PE2), received 0.2 mL/100 g α-linolenic acid rich
phytosterol esters by gavage twice a day at 9 AM and
5 PM, respectively; (IV) α-linolenic acid rich phytosterol
esters group 3 (ALA-PE3), received 0.133 mL/100 g α-
linolenic acid rich phytosterol esters by gavage three
times a day at 9 AM, 1 PM and 5 PM, respectively; (V)
α-linolenic acid rich phytosterol esters group 4 (ALA-
PE4), received 0.1 mL/100 g α-linolenic acid rich phytos-
terol esters by gavage four times a day at 9 AM,
11:30 AM 2:30 PM and 5 PM, respectively.
Feed and water were changed every day, and the body
weights of the hamsters were recorded once per week.
Daily feed (g) was calculated on a per rat daily basis. At
the end of the experiment, the hamsters were sacrificed
after an overnight fasting. Plasma was collected from
blood by centrifuge at 3500 g for 10 min, and then
stored at −80 °C. Fresh liver and small intestine samples
were quickly frozen by liquid nitrogen and stored
at–80 °C for further analysis.
Analysis of plasma and hepatic lipid parameters
Plasma TC, TG, LDL-C and HDL-C concentrations were
determined by enzymatic colorimetric methods using
commercial kits (Biosino Bio-Technology and Science Inc.,
Beijing, China). Hepatic lipids were extracted as previously
described by Folch et al. (1957) [32]. Briefly, approximately
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100 mg of liver tissue was homogenized in chloroform/
methanol (2/1, v/v) to a final volume of 20 times the tissue
sample. The homogenate was filtered with Whatman No.1
filter paper to obtain the liquid phase. The extract was then
dried under N2 and resuspended in isopropanol. Hepatic
TC and TG levels were measured using the same enzymatic
commercial kits as the plasma analysis.
Analysis of plasma antioxidant capacity
The T-AOC level was determined using the Fe3+ reduction
method according to the commercial test kits (Nanjing
Jiancheng Bioengineering Institute, Nanjing, China). The
SOD activity was estimated basing on the xanthine-
xanthine oxidase-nitrite method according to Fridovich
with slight modification [33]. The GSH content was esti-
mated by the use of commercial kit (Nanjing Jiancheng
Bioengineering Institute, China) based on the method of
Eady et al. [34]. GPX activity was determined by the use of
commercial kit (Nanjing Jiancheng Bioengineering Institute,
China) based on the method of Sazuka et al. [35].
Analysis of hepatic fatty acid composition
Fatty acids were transmethylated based on the method
of Bicalho et al. [36]. In brief, the total lipid extracts in
chloroform were evaporated to dryness under a stream
of N2 at 40 °C. And 500 μL of freshly prepared 5 %
acetylchloride (Sigma–Aldrich) in methanol (HPLC
grade, Merck KGaA, Darmstadt) was added to each
tube. The tubes were tightly capped and heated for
30 min at 90 °C. After cooling, 200 μL of n-hexane
(HPLC grade, Merck KGaA, Darmstadt) was added and
the tubes were shaken for 1 min. N-hexane containing fatty
acid methyl esters was directly taken for gas chromato-
graphic analysis. Fatty acid methyl esters were separated
using Agilent 6890 GC with an HP-88 fused silica capillary
column (100 m× 0.25 mm, ID × 0.20 μm thickness, J&W
112-88A7, Agilent Technologies) and a flame ionization
detector. The oven temperature started at 50 °C and held
for 1 min, increased to 175 °C at 15 °C/min, and then in-
creased to 250 °C at 1 °C/min. The injector temperature
and detector temperature were set at 250 °C. Helium was
used as a carrier gas (1.5 mL/min), and the injection vol-
ume was 1 μL in a splitless mode. The fatty acid methyl es-
ters were identified by comparing with authentic standards
(GL-463, Nu-Chek Prep) and their relative concentrations
(mol % of total lipids) were calculated by the percentage
area method with proper normalization.
Real-time quantitative polymerase chain reaction (PCR)
analysis
Total RNA was extracted from small intestine tissue
using the TRIzol reagent (Ambion®, life technologies,
USA) according to the manufacturer’s instructions. Mes-
senger RNA (mRNA) expressions of the target genes
were quantified by quantitative reverse transcriptase
(qRT)-PCR using the SYBR green-based kit (TaKaRa
BIO Inc., Dalian) with specific primers using an RT-PCR
machine (7900HT; Applied Biosystems, Forster, CA,
USA). The mRNA level of 18S rRNA was quantified as
an endogenous control, and results were calculated by a
comparative 2−ΔΔCt method. Primer sequences were as
follows: ABCG5 (AF312713), 5’- TGATTGGCAGCTAT
AATTTTGGG-3’ and 5’- GTTGGGCTGCGATGGAAA-
3’; ABCG8 (AF324495), 5’- TGCTGGCCATCATAGG
GAG-3’ and 5’- TCCTGATTTCATCTTGCCACC-3’;
NPC1L1 (AY437866), 5’- CCTGACCTTTATAGAACT
CACCACAGA-3’ and 5’- GGGCCAAAATGCTCGTC




All data were presented as the mean ± SD. The data were
analyzed using one-way ANOVA followed by Tukey’s test
to evaluate differences between groups using SPSS statis-
tical software. Differences among groups were considered
significant at p < 0.05.
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